Biomerica (BMRA) Enterprise Value Growth (1y) (2011 - 2026)
Biomerica (BMRA) Enterprise Value Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 56.31% |
| Nov 30, 2025 | -7.21% |
| Aug 31, 2025 | -8.26% |
| May 31, 2025 | 26.67% |
| Feb 28, 2025 | 42.51% |
| Nov 30, 2024 | 66.75% |
| Aug 31, 2024 | 64.70% |
| May 31, 2024 | 57.09% |
| Feb 29, 2024 | -59.00% |
| Nov 30, 2023 | -40.81% |
| Aug 31, 2023 | -31.49% |
| May 31, 2023 | -64.26% |
| Feb 28, 2023 | 67.12% |
| Nov 30, 2022 | 29.62% |
| Aug 31, 2022 | -21.58% |
| May 31, 2022 | -40.90% |
| Feb 28, 2022 | -92.96% |
| Nov 30, 2021 | -26.66% |
| Aug 31, 2021 | 28.25% |
| May 31, 2021 | 51.40% |